Presented by:

Division of Hematology and Medical Oncology
The Tisch Cancer Institute

Speakers:

Nina Andrea Bickell, MD, MPH
Associate Director, Community Engaged and Equity Research
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
&
Grace Hillyer, EdD, MPH
Assistant Professor of Epidemiology
Mailman School of Public Health
Columbia University

Target Audience: 

Educate Hematologists and Oncologists about the newest options for treatment and diagnosis in cancer medicine.
1. Identify the multilevel barriers, including implicit bias, to the enrollment of Black, Indigenous, and People of Color (BIPOC) patients with cancer to clinical trials
2. Understand the implications of lack of diversity in clinical trial participation on patient and trial outcomes